First Time Loading...
C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 15.52 PLN 2.37% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

CLN Price Targets Summary
Celon Pharma SA

Wall Street analysts forecast CLN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLN is 15.2 PLN with a low forecast of 12.12 PLN and a high forecast of 17.54 PLN.

Lowest
Price Target
12.12 PLN
22% Downside
Average
Price Target
15.2 PLN
2% Downside
Highest
Price Target
17.54 PLN
13% Upside
Celon Pharma SA Competitors:
Price Targets
002626
Xiamen Kingdomway Group Co
51% Upside
UCB
Ucb SA
6% Upside
300765
CSPC Innovation Pharmaceutical Co Ltd
22% Upside
000423
Dong-E-E-Jiao Co Ltd
5% Upside
ASRT
Assertio Holdings Inc
203% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
57% Upside
APLLTD
Alembic Pharmaceuticals Ltd
12% Downside
CAPLIPOINT
Caplin Point Laboratories Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Celon Pharma SA

For the last 6 years the compound annual growth rate for Celon Pharma SA's revenue is 7%. The projected CAGR for the next 4 years is 1%.

7%
Past Growth
1%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Celon Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Celon Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLN's stock price target?
Price Target
15.2 PLN

According to Wall Street analysts, the average 1-year price target for CLN is 15.2 PLN with a low forecast of 12.12 PLN and a high forecast of 17.54 PLN.

What is Celon Pharma SA's Revenue forecast?
Projected CAGR
1%

For the last 6 years the compound annual growth rate for Celon Pharma SA's revenue is 7%. The projected CAGR for the next 4 years is 1%.